Halozyme Therapeutics, Inc. (HALO)

61.90 -0.75 (-1.20%) USD  |  NASDAQ  |  Dec 11, 16:00
61.91 +0.01 (+0.02%) After-Hours: 20:00
More

Halozyme Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Twist Bioscience Corp. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade